What is it about?
The IFCC Taskforce on COVID-19 conducted a global survey of laboratories at the end of April 2020 to understand the biosafey practices to mitigate the risk brought on by the pandemic. This article describes the data garnered with this survey.
Featured Image
Read the Original
This page is a summary of: Laboratory practices to mitigate biohazard risks during the COVID-19 outbreak: an IFCC global survey, Clinical Chemistry and Laboratory Medicine (CCLM), June 2020, De Gruyter,
DOI: 10.1515/cclm-2020-0711.
You can read the full text:
Contributors
Be the first to contribute to this page
